<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To investigate the contribution of polymorphisms in nuclear receptors to risk of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Genotypes of nuclear factor (NF)-κB (NFKB1) NFκB -94ins/del (rs28362491); peroxisome proliferator-activated receptor (PPAR)-γ (PPARγ) PPARγ Pro12Ala (rs 1801282) and C1431T (rs 3856806); <z:chebi fb="0" ids="8386">pregnane</z:chebi> X receptor (PXR) (NR1I2) PXR A-24381C (rs1523127), C8055T (2276707), and A7635G (rs 6785049); and liver X receptor (LXR) (NR1H2) LXR T-rs1405655-C and T-rs2695121-C were assessed in a Danish case-control study of 327 <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> patients, 495 <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) patients, and 779 healthy controls </plain></SENT>
<SENT sid="2" pm="."><plain>Odds ratio (OR) and 95% CI were estimated by logistic regression models </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The PXR A7635G variant, the PPARγ Pro12Ala and LXR T-rs2695121-C homozygous variant genotypes were associated with risk of UC (OR: 1.31, 95% CI: 1.03-1.66, P = 0.03, OR: 2.30, 95% CI: 1.04-5.08, P = 0.04, and OR: 1.41, 95% CI: 1.00-1.98, P = 0.05, respectively) compared to the corresponding homozygous <z:mp ids='MP_0002169'>wild-type</z:mp> genotypes </plain></SENT>
<SENT sid="4" pm="."><plain>Among never smokers, PXR A7635G and the LXR T-rs1405655-C and T-rs2695121-C variant genotypes were associated with risk of IBD (OR: 1.41, 95% CI: 1.05-1.91, P = 0.02, OR: 1.63, 95% CI: 1.21-2.20, P = 0.001, and OR: 2.02, 95% CI: 1.36-2.99, P = 0.0005, respectively) compared to the respective homozygous variant genotypes </plain></SENT>
<SENT sid="5" pm="."><plain>PXR A7635G (rs6785049) variant genotype was associated with a higher risk of UC diagnosis before the age of 40 years and with a higher risk of <z:e sem="disease" ids="C0849867" disease_type="Disease or Syndrome" abbrv="">extensive disease</z:e> (OR: 1.34, 95% CI: 1.03-1.75 and OR: 2.49, 95% CI: 1.24-5.03, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Common PXR and LXR polymorphisms may contribute to risk of IBD, especially among never smokers </plain></SENT>
</text></document>